Katarina Luptakova

Insider Reports History

Entity
Individual
Location
C/O Xilio Therapeutics, Inc., 828 Winter Street, Waltham, MA
Signature
/s/ Kevin Brennan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Katarina Luptakova:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. CHIEF MEDICAL OFFICER Restricted Stock Units 49.9K $49.1K $0.98 Jan 1, 2025 Direct
Xilio Therapeutics, Inc. CHIEF MEDICAL OFFICER Common Stock 16.6K $16.4K $0.98 Jan 1, 2025 Direct
Xilio Therapeutics, Inc. CHIEF MEDICAL OFFICER Stock Option (right to buy) 200K Jan 1, 2025 Direct

Insider Reports Filed by Katarina Luptakova

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XLO Xilio Therapeutics, Inc. Jan 1, 2025 3 $0 4 Jan 3, 2025 CHIEF MEDICAL OFFICER
XLO Xilio Therapeutics, Inc. May 1, 2024 1 $0 4 May 3, 2024 CHIEF MEDICAL OFFICER
XLO Xilio Therapeutics, Inc. Jan 1, 2024 1 $0 4 Jan 3, 2024 CHIEF MEDICAL OFFICER
XLO Xilio Therapeutics, Inc. Sep 5, 2023 1 $0 4 Sep 7, 2023 Chief Medical Officer
XLO Xilio Therapeutics, Inc. Sep 5, 2023 0 $0 3 Sep 7, 2023 Chief Medical Officer